Posts

Posted on

Preview Our New Web Site Design

by and
0 comments

Redesigned NIGMS Web siteA new look and feel for the NIGMS Web site will launch in the next few weeks. The design incorporates feedback we received during usability testing with individuals representing key target audiences—scientists, administrators, educators, news media and the public—as well as from our recent user satisfaction survey and other data.

The new design features a fresh color palette based on the NIGMS logo, fewer top-level tabs and a reorganization of how some content is presented. We also make it easier for users to connect with us through social media like Twitter Link to external web site and Facebook Link to external web site.

Even with these latest enhancements, the site is always a work in progress. We welcome your input and suggestions at any time.

UPDATE: The redesigned NIGMS Web site has launched. While redirects are in place, please be sure to check your bookmarks as some page URLs may have changed.

Posted on

High-Resolution Excitement at the 25th AIDS-Related Structural Biology Meeting

by
0 comments
HIV Poster. Image copyright David S. Goodsell, RCSB PDB, www.pdb.org

 

Image copyright David S. Goodsell, RCSB PDB, www.pdb.org

An exceptional array of structural biologists, cell biologists, virologists and other researchers gathered at NIH late last month to discuss achievements, applications and future directions in AIDS-related structural biology. The group was attending the 25th Annual Meeting of the Groups Studying the Structures of AIDS-Related Systems and Their Application to Targeted Drug Design.

I was extraordinarily impressed by the quality of the science, the passion with which it was presented and the interactive culture of the community.

The meeting began with a keynote address by Steve Harrison of Harvard Medical School. He provided valuable historical perspective and then outlined major challenges facing the field. Two days later, the event concluded with a provocative talk by Manuel Navia of Oxford Bioscience Partners about the economics of bringing new lead compounds through the drug development pipeline.

In between were sessions on the HIV life cycle, HIV host-pathogen interactions, imaging, latency, viral host recognition and structure-based drug design and resistance. There were also lively poster sessions showcasing more than 70 projects.

Approximately 2.8% of the NIGMS budget supports research related to AIDS, which includes individual grants, program projects, centers and institutional training grants.

A major focus of our current AIDS-related structural biology efforts is three P50 Centers for the Determination of Structures of HIV/Host Complexes. With cofunding from the National Institute of Allergy and Infectious Diseases, we support the Center for HIV Protein Interactions at the University of Pittsburgh; the Center for the Structural Biology of Cellular Host Elements in Egress, Trafficking, and Assembly of HIV at the University of Utah; and the HIV Accessory and Regulatory Complexes Center at the University of California, San Francisco. These centers use a comprehensive, collaborative approach that engages the larger biological community involved in HIV-cell complex research.

Because the funding initiative for the P50 centers expires next year, we solicited feedback on the program from meeting attendees. We also asked them about emerging scientific opportunities in the field and the best way to move forward. We welcome your input on these topics, too. We’ll talk more about future of NIGMS AIDS-related funding opportunity announcements at the May 2011 meeting of the National Advisory General Medical Sciences Council.

Although many scientific questions remain, the 25th anniversary meeting underscored how basic research on the structure of HIV-1 and interacting host proteins has significantly increased our understanding of virus biology and informed structure-based therapeutic approaches.

Posted on

Inspired by Stellar Student Scientists

by
0 comments

Intel Science Talent SearchI recently had the pleasure of attending the awards ceremony for this year’s Intel Science Talent Search. Before the award announcements, I enjoyed visiting the posters of many of the 40 finalists. These high school students displayed impressive knowledge and passion for their projects, many of which were quite sophisticated. A number of the finalists were even savvy enough to test my understanding so they could pitch their presentation to me at an appropriate level.

A highlight of the evening was definitely the award presentations themselves. The winners were clearly thrilled to be recognized among an incredibly accomplished group of young scientists. The speakers—who included Elizabeth Marincola Link to external web site, president of the Society for Science & the Public, which runs the Science Talent Search program; Paul Otellini Link to external web site, president and CEO of Intel; Miles O’Brien, who covers science on the PBS NewsHour; and one of the students, selected by his peers—uniformly stressed the importance of communicating the excitement and value of science to the public.

This is a good reminder to all of us in the scientific community about our responsibility to reach out broadly to explain what we do and why we do it in understandable terms that can inform the public and potentially inspire new members of future generations of scientists.

Posted on

The Search Is On for a New NIGMS Director

by
0 comments

As co-chair of the search committee for a new NIGMS Director, I want to tell you about the committee and ask for your help in identifying candidates for this critical position.

The committee members are:

  • Harold Varmus, Director, National Cancer Institute (co-chair)
  • Story Landis, Director, National Institute of Neurological Disorders and Stroke (co-chair)
  • Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases
  • Eric Green, Director, National Human Genome Research Institute
  • Roderic Pettigrew, Director, National Institute of Biomedical Imaging and Bioengineering
  • Carol Greider, Professor, Johns Hopkins University
  • Stan Fields, Professor, University of Washington
  • Steven McKnight, Professor, University of Texas Southwestern Medical Center
  • Joan Steitz, Professor, Yale University

Not surprisingly, we’re looking for an exceptional leader with strategic vision and a distinguished record of research and management achievements. NIH Director Francis Collins met with us last week and emphasized the need to find an outstanding person who can speak compellingly about the importance of basic research, can direct the Institute’s efforts to support exciting research across a broad range of disciplines and is committed to fulfilling the Institute’s mission of training the next generation of scientists.

For more about the job qualifications, how to apply and other details, see the official vacancy announcement at http://www.jobs.nih.gov/vacancies/executive/nigmsdirector.htm.

The application receipt deadline is April 29, 2011.

Please share this information with others who might be interested.

UPDATE: The application receipt deadline has been extended to May 13, 2011.

Posted on

Collaborative Science Supplement Requests – Next Deadline Is in May

by
2 comments

Have an idea for a great collaboration that will advance your NIGMS-funded research project? If your current award has active funding through at least November 30, 2012, you may be eligible to jump-start your idea with an administrative supplement for collaborative science. The next submission deadline is May 15, 2011.

To ensure that your project is appropriate for this program, please review the funding opportunity announcement. You should also discuss the project idea with your NIGMS program director before preparing an application. For general questions about the program, contact me or Marion Zatz.

Posted on

Wanted: Program Director, Genetic Mechanisms

by
0 comments

We’re looking for a program director (also known as a “health scientist administrator/program officer”) to oversee research grants and other activities related to mechanistic aspects of one or more of the following areas: DNA replication, recombination, mutagenesis and repair; gene expression; protein synthesis; or related cellular processes. Candidates should have expertise in state-of-the-art genetics, molecular biology and/or genomics. The position is in the Genetic Mechanisms Branch of our Division of Genetics and Developmental Biology.

Please see the NIH HSA Web site for position requirements and detailed application procedures. Note that this is a global recruitment for program officer positions throughout NIH. To be considered for the genetic mechanisms position in NIGMS, be sure to emphasize aspects of your training, expertise and research interests that make it clear that you’re a good fit for what we’re looking for, as described above.

If you’re interested, act quickly, as this vacancy announcement closes on March 14, 2011.

Not looking for a position right now? Please help us out by forwarding this information to others who might be interested.

Posted on

Apply for a Scientific Review Job in NIGMS

by
2 comments

We’re advertising for a scientific review officer to oversee the peer review of applications for a broad range of research and training programs, including programs aimed at increasing the diversity of the scientific workforce. We particularly seek someone with expertise in biochemistry, biophysics, computational biology and bioinformatics, and/or pharmacology to join our busy and interactive scientific review team, but the job involves setting up and managing review groups across the entire range of biomedical, clinical and behavioral fields we support.

For details on the position and application process, see the NIH HSA Web site. The vacancy announcement closes on March 14, 2011.

Posted on

Send Input on Single-Cell Analysis

by
4 comments

Cool Video: Leading Cells with LightNIH is seeking broad input from the scientific community on challenges and opportunities in single-cell analysis, a topic of great interest and relevance to many NIGMS grantees and applicants. Please help NIH shape its future programs in this emerging research area by sending in your opinions. The request for information (RFI) asks for responses on topics including:

  • Current conceptual, technical and/or methodological challenges in the field;
  • Major biomedical research questions that can be addressed by single-cell analysis; and
  • The highest priority tools and resources needed to move forward.

We hope you’ll take the time to weigh in with your opinions and specific examples between now and the March 18 response deadline.

Let me know if you would like to learn more about trans-NIH activities in this area, as I’m a member of the group that issued this RFI—the Single Cell Analysis Working Group of the NIH Common Fund (formerly known as the NIH Roadmap), which provides strategic planning, coordination and support for programs that cut across NIH institutes and centers.

Posted on

Proposed NIH Reorganization and NIGMS

by
8 comments

NCRR task force recommendations.I have previously noted that NIH has proposed creating a new entity, the National Center for Advancing Translational Sciences (NCATS), to house a number of existing programs relating to the discipline of translational science and the development of novel therapeutics. Plans for NCATS have been coupled to a proposal to dismantle the National Center for Research Resources (NCRR), in part because the largest program within NCRR, the Clinical and Translational Science Awards, would be transferred to NCATS and in part because of a statutory limitation on the number of institutes and centers at NIH.

NIH leadership established a task force to determine the placement of NCRR programs within NIH. This group initially developed a “straw model” for discussion and more recently submitted its recommendations to the NIH Director. The recommendations include transferring the Institutional Development Award (IDeA) program and some Biomedical Technology Research Centers and other technology research and development grants to NIGMS at the beginning of Fiscal Year 2012.

As you may be aware, I have expressed concerns about the processes associated with the proposal to abolish NCRR. I hope it is clear that my concerns relate to the processes and not to the NCRR programs, which I hold in very high regard. This opinion is also clearly shared by many others in the scientific community, based on comments on the Feedback NIH site and in other venues.

While there are several additional steps that would need to occur before organizational changes could take place, we at NIGMS are already deepening our understanding of the NCRR programs through meetings with NCRR staff and others directly familiar with the programs. We welcome your input, as well, particularly if you have experience with these NCRR programs. Please comment here or contact me directly.

Posted on

Enhancing Peer Review Survey Results

by
5 comments

One of the key principles of the NIH Enhancing Peer Review efforts was a commitment to a continuous review of peer review. In that spirit, NIH conducted a broad survey of grant applicants, reviewers, advisory council members and NIH program and review officers to examine the perceived value of many of the changes that were made. The results of this survey are now available. The report analyzes responses from these groups on topics including the nine-point scoring scale, criterion scores, consistency, bulleted critiques, enhanced review criteria and the clustering of new investigator and clinical research applications.

NIH Enhancing Peer Review Survey criterion score responses from applicants.

NIH Enhancing Peer Review Survey criterion score responses from applicants.

Please feel free to comment here or on Rock Talk, where NIH Deputy Director for Extramural Research Sally Rockey recently mentioned the release of this survey.